WEBINAR

What’s the future of aortic valve replacement?

With Matt Brady, Ros Lancaster, Geoff Moggridge and Lin Bowker-Lonnecker
29 SEP 2020

Our panel of experts Matt Brady, Ros Lancaster, Professor Geoff Moggridge and Lin Bowker-Lonnecker share their insights from both an academic and commercial perspective, on the impact of a range of current and future innovation pressures on the exciting and growing medical device space of TAVR (Transcatheter Aortic Valve Replacement).

Connect with the speakers

Matt Brady

Matt Brady

Partner & Head of Medical Therapy

Ros Lancaster

Ros Lancaster

Insights for innovation consultant

Geoff Moggridge

Geoff Moggridge

Professor, University of Cambridge

Lin Bowker-Lonnecker

Lin Bowker-Lonnecker

Medical Device Engineer, Arete Medical Tecnologies